INS and type 1 diabetes mellitus: The adult population suffering from diabetes in 2021 was approximately 537 million and this number is predicted to rise to 783 million by 2045.1 To date, the treatment of type 1 diabetes involves insulin-based therapy which has the double disadvantage of subcutaneous administration and the possible onset of insulin resistance phenomena.